Rethinking cocaine-associated chest pain and acute coronary syndromes

Mayo Clinic Proceedings

Volumn 86, Issue 12, 2011, Pages 1198-1207

  Finkel, Jonathan B ^a   Marhefka, Gregary D ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; COCAINE; DEXMEDETOMIDINE; GLYCERYL TRINITRATE; LABETALOL; PHENTOLAMINE; PLACEBO;

ACUTE CORONARY SYNDROME; ALGORITHM; BLOOD CLOT LYSIS; CARDIOMYOPATHY; CARDIOVASCULAR EFFECT; CLINICAL PRACTICE; COCAINE ASSOCIATED CHEST PAIN; COCAINE DEPENDENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DISEASE MARKER; ELECTROCARDIOGRAM; EMERGENCY WARD; EVIDENCE BASED MEDICINE; HEART MUSCLE ISCHEMIA; HUMAN; PATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; REVIEW; THORAX PAIN; TREATMENT OUTCOME;

EID: 83155173456     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0338     Document Type: Review

References (96)

1. Gold M. Cocaine. New York, NY: Plenum Publishing Corporation; 1993:11-24.
2. Bock G. Cocaine: Scientific and Social Dimensions. New York, NY: John Wiley and Sons Inc; 1992:7-19.
3. History of Cocaine. http://www.historyofcocaine.net/. Accessed August 16, 2011.
4. US Department of Health and Human Services (DHS); Office of Applied Studies. Results from the 2008 National Survey on Drug Use and Health: National Findings. http://oas.samhsa.gov/nsduh/2k8nsduh/2k8Results.cfm. Accessed August 16, 2011.
5. US Department of Health and Human Services (DHS), Substance Abuse and Mental Health Service Administration, Office of Applied Studies. Drug Abuse Warning Network, 2007: National Estimates of Drug-Related Emergency Department Visits. Rockville, MD: 2010. https://dawninfo.samhsa.govfiles/ED2007/DAWN2k7ED. pdf. Accessed August 16, 2011.
6. Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17-36.
7. US Department of Health and Human Services (DHS), Substance Abuse and Mental Health Service Administration, Office of Applied Studies. The DAWN Report: Emergency Department Visits Involving Illicit Drug Use by Older Adults: 2008. Rockville, MD. Published September 9, 2010. http://oas.samhsa.gov/2k10/ DAWN015/IllicitAbuseHTML.pdf. Accessed August 16, 2011.
8. Boehrer JD, Moliterno DJ, Willard JE, et al. Hemodynamic effects of intranasal cocaine in humans. J Am Coll Cardiol. 1992;20:90-93.
9. Foltin RW, Ward AS, Haney M, et al. The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend. 2003;70:149-157. (Pubitemid 37034167)
10. Resnick RB, Kestenbaum RS, Schwartz ELK. Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science. 1977;195(4279):696-698. (Pubitemid 8055719)
11. Fischman MW, Schuster CR, Javaid J, et al. Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther. 1985;235(3):677-682. (Pubitemid 16210733)
12. Whitby LG, Hertting G, Axelrod J. Effect of Cocaine on the disposition of noradrenaline labeled with tritium. Nature. 1960;187:604-605.
13. Muscholl E. Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Br J Pharmacol Chemother. 1961;16:352-359.
14. Tuncel M, Wang Z, Arbique D, et al. Mechanism of the blood pressure-raising effect of cocaine in humans. Circulation. 2002;105(9):1054- 1059. (Pubitemid 34212613)
15. Brogan WC III, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol. 1991;18(2):581-586.
16. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330(7):454-459. (Pubitemid 24058933)
17. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med. 1993;94(6):608-610. (Pubitemid 23166707)
18. Dressler FA, Malekzadeh S, Roberts WC. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol. 1990;65(5):303-308. (Pubitemid 20038910)
19. Satran A, Bart BA, Henry CR, et al. Increased prevalence of coronary artery aneurysms among cocaine users. Circulation. 2005;111(19):2424-2429. (Pubitemid 40696129)
20. Apostolakis E, Tsigkas G, Baikoussis NG, Koniari I, Alexopoulos D. Acute left main coronary artery thrombosis due to cocaine use. J Cardiothorac Surg. 2010;5:65.
21. Robaei D, Grieve SM, Nelson GC, Bhindi R, Figtree GA. Cocaine-induced epicardial coronary artery thrombosis resulting in extensive myocardial injury assessed by cardiac magnetic resonance imaging. Eur Heart J. 2010;31(20):2446.
22. Mongeon FP, Rinfret S. Left main coronary artery occlusion with myocardial infarction in a cocaine user. Successful angioplasty with a drug-eluting stent. Can J Cardiol. 2008;24(5):e30-e32.
23. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WRY. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000;83(6):688-695. (Pubitemid 30345974)
24. Kugelmass AD, Shannon RP, Yeo EL, Ware JA. Intravenous cocaine induces platelet activation in the conscious dog. Circulation. 1995;91(5):1336-1340.
25. Siegel AJ, Mendelson JH, Sholar MB, et al. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. Am J Cardiol. 2002;89(9):1133-1135. (Pubitemid 34462865)
26. Pradhan L, Mondal D, Chandra S, Ali M, Agrawal KC. Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide. Cardiovasc Toxicol. 2008;8(4):161-171.
27. Böhm F, Pernow J. The importance of endothelin-1 for vascular dysfunction in cardiovascular disease. Cardiovasc Res. 2007;76(1):8-18. (Pubitemid 47362047)
28. Jonas MA, Oates JA, Ockene JK, Hennekens CH; American Heart Association. Statement on smoking and cardiovascular disease for healthcare professionals. Circulation. 1992;86:1664-1669.
29. Iacobellis G, Kemp W. Cardiomyocyte apoptosis in cocaine-induced myocarditis with involvement of bundle of His and left bundle branch. Int J Cardiol. 2006;112(1):116-118. (Pubitemid 44247176)
30. Peng SK, French WJ, Pelikan PC. Direct cocaine cardiotoxicity demonstrated by endomyocardial biopsy. Arch Pathol Lab Med. 1989;113(8):842-845. (Pubitemid 19206383)
31. Fan L, Sawbridge D, George V, et al. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J Pharmacol Exp Ther. 2009;328(1):99-106.
32. Chen Y, Ke Q, Xiao YF, et al. Cocaine and catecholamines enhance inflammatory cell retention in the coronary circulation of mice by upregulation of adhesion molecules. Am J Physiol Heart Circ Physiol. 2005;288(5):H2323-H2331. (Pubitemid 40604121)
33. Bertolet BD, Freund G, Martin CA, Perchalski DL, Williams CM, Pepine CJ. Unrecognized left ventricular dysfunction in an apparently healthy cocaine abuse population. Clin Cardiol. 1990;13(5):323-328. (Pubitemid 20172850)
34. Eisenberg MJ, Yakel DL, Mendelson J, Redberg RF, Jones RT, Foster E. Immediate effects of intravenous cocaine on the thoracic aorta and coronary arteries: a transesophageal echocardiographic study. Chest. 1996;110(1):147-154. (Pubitemid 26249316)
35. Su J, Li J, Li W, Altura B, Altura B. Cocaine induces apoptosis in primary cultured rat aortic vascular smooth muscle cells: possible relationship to aortic dissection, atherosclerosis, and hypertension. Int J Toxicol. 2004;23(4):233-237. (Pubitemid 39346622)
36. Eagle KA, Isselbacher EM, DeSanctis RW. Cocaine-related aortic dissection in perspective. Circulation. 2002;105:1529-1530. (Pubitemid 34297624)
37. Hsue PY, Salinas C, Bolger AF, et al. Acute aortic dissection induced by crack cocaine. Circulation. 2002;105:1592-1595. (Pubitemid 34297638)
38. Daniel JC, Huynh TT, Zhou W, et al. Acute aortic dissection associated with use of cocaine. J Vasc Surg. 2007;46:427-433. (Pubitemid 47371065)
39. Feldman JA, Fish SS, Beshansky JR, Griffith JL, Woolard RH, Selker HP. Acute cardiac ischemia in patients with cocaine-associated complaints: results of a multicenter trial. Ann Emerg Med. 2000;36(5):469-476.
40. Hollander JE, Hoffman RS, Gennis P, et al. Cocaine Associated Chest Pain (COCHPA) Study Group. Prospective multicenter evaluation of cocaine-associated chest pain. Acad Emerg Med. 1994;1(4):330-339.
41. Brody SL, Slovis CM, Wrenn KD. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med. 1990;88(4):325-331. (Pubitemid 20147265)
42. Lakowski JM, Galloway MP, White FJ. Cocaine Pharmacology, Physiology and Clinical Strategy. Boca Raton, FL: CRC Press; 1992:35-51.
43. Hollander JE, Hoffman RS, Burstein JL, Shih RD, Thode HC Jr; Cocaine-Associated Myocardial Infarction Study Group. Cocaine-associated myocardial infarction: mortality and complications. Arch Intern Med. 1995;155(10):1081-1086.
44. Erzouki HK, Baum I, Goldberg SR, Schindler CW. Comparison of the effects of cocaine and its metabolites on cardiovascular function in anesthetized rats. J Cardiovasc Pharmacol. 1993;22(4):557-563. (Pubitemid 23286751)
45. Brogan WC III, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med. 1992;116(7):556-561.
46. Jatlow P, Elsworth JD, Bradberry CW, et al. Cocaethylene: a neuropharmacologically active metabolite associated with concurrent cocaine-ethanol ingestion. Life Sci. 1991;48(18):1787-1794.
47. Hearn WL, Rose S, Wagner J, Ciarleglio A, Mash DC. Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol Biochem Behav. 1991;39(2):531-533.
48. Wilson LD, French S. Cocaethylene's effects on coronary artery blood flow and cardiac function in a canine model. J Toxicol Clin Toxicol. 2002;40(5):535-546. (Pubitemid 34971204)
49. Wilson LD, Malik M, Willson H. Cocaine and ethanol: combined effects on coronary artery blood flow and myocardial function in dogs. Acad Emerg Med. 2009;16(7):646-655.
50. Carrillo X, Curós A, Muga R, et al. Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes. Eur Heart J. 2011;32:1244-1250.
51. Jones JH, Weir W. Cocaine-induced chest pain. Clin Lab Med. 2006;26:127-146.
52. Amin M, Gabelman G, Karpel J, Buttrick P. Acute myocardial infarction and chest pain syndromes after cocaine use. Am J Cardiol. 1990;66(20):1434-1437.
53. Frishman WH. Carvedilol. N Engl J Med. 1998;339(24):1759-1765.
54. Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction: a placebo-controlled, randomized trial. Circulation. 1997;96(1):183-191. (Pubitemid 27298420)
55. Hollander JE, Levitt MA, Young GP, Briglia E, Wetli CV, Gawad Y. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J. 1998;135(2 Pt 1):245-252. (Pubitemid 28139164)
56. Kontos MC, Anderson FP, Ornato JP, Tatum JL, Jesse RL. Utility of troponin I in patients with cocaine-associated chest pain. Acad Emerg Med. 2002;9(10):1007-1013. (Pubitemid 35168297)
57. Kontos MC, Jesse RL, Tatum JL, Ornato JP. Coronary angiographic findings in patients with cocaine-associated chest pain. J Emerg Med. 2003;24(1):9-13. (Pubitemid 36110668)
58. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/ Non ST-Elevation Myocardial Infarction: a Report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;57:e215-e367.
59. Chase M, Brown AM, Robey JL, et al. Application of the TIMI risk score in ED patients with cocaine-associated chest pain. Am J Emerg Med. 2007;25(9):1015-1018. (Pubitemid 350101040)
60. Weber JE, Shofer FS, Larkin GL, Kalaria AS, Hollander JE. Validation of a brief observation period for patients with cocaine-associated chest pain. N Engl J Med. 2003;348(6):510-517. (Pubitemid 36159886)
61. Cunningham R, Walton MA, Weber JE, et al. One-year medical outcomes and emergency department recidivism after emergency department observation for cocaine-associated chest pain. Ann Emerg Med. 2009;53(3):310-320.
62. Kontos MC, Schmidt KL, Nicholson CS, Ornato JP, Jesse RL, Tatum JL. Myocardial perfusion imaging with technetium-99m sestamibi in patients with cocaine-associated chest pain. Ann Emerg Med. 1999;33(6):639-645. (Pubitemid 29254732)
63. Hollander JE, Chang AM, Shofer FS, et al. One-year outcomes following coronary computerized tomographic angiography for evaluation of emergency department patients with potential acute coronary syndrome. Acad Emerg Med. 2009;16(8):693-698.
64. Walsh K, Chang AM, Perrone J, et al. Coronary computerized tomography angiography for rapid discharge of low-risk patients with cocaine-associated chest pain. J Med Toxicol. 2009;5(3):111-119.
65. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction - Executive Summary: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110:588-636. (Pubitemid 39036178)
66. Hollander JE. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333(19):1267-1272.
67. McCord J, Jneid H, Hollander J, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008;117:1897-1907. (Pubitemid 351507480)
68. Baumann BM, Perrone J, Hornig SE, Shofer FS, Hollander JE. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad Emerg Med. 2000;7(8):878-885. (Pubitemid 30626283)
69. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerin or nitroglycerin alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med. 2003;21(1):39-42. (Pubitemid 36176129)
70. Hoskins MH, Leleiko RM, Ramos JJ, Sola S, Caneer PM, Khan BV. Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use. J Cardiovasc Pharmacol Ther. 2010;15(1):47-52.
71. Negus BH, Willard JE, Hillis LD, et al. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am J Cardiol. 1994;73(7):510-513. (Pubitemid 24096216)
72. Derlet RW, Albertson TE. Potentiation of cocaine toxicity with calcium channel blockers. Am J Emerg Med. 1989;7(5):464-468. (Pubitemid 19235800)
73. Nahas G, Trouvé R, Demus JR, von Sitbon M. A calcium-channel blocker as antidote to the cardiac effects of cocaine intoxication. N Engl J Med. 1985;313(8):519-520. (Pubitemid 15015087)
74. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet. 1986;2:57-66.
75. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction: patient population. Am J Cardiol. 1985;56:10G-14G.
76. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine, induced coronary vasoconstriction by beta adrenergic blockade. Ann Intern Med. 1990;112:897-903. (Pubitemid 20193673)
77. Shannon RP, Stambler BS, Komamura K, Ihara T, Vatner SF. Cholinergic modulation of the coronary vasoconstriction induced by cocaine in conscious dogs. Circulation. 1993;87(3):939-949. (Pubitemid 23070826)
78. Kenny D, Pagel PS, Warltier DC. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetolol. Basic Res Cardiol. 1992;87:465-477.
79. Vargas R, Gillis RA, Ramwell PW. Propranolol promotes cocaine-induced spasm of porcine coronary artery. J Pharmacol Exp Ther. 1991;257:644-646.
80. Rappolt RT, Gay G, Inaba DS, Rappolt NR. Propranolol in cocaine toxicity [letter]. Lancet. 1976;2(7986):640-641.
81. Catravas JD, Waters IW. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther. 1981;217(2):350-356. (Pubitemid 11112724)
82. Rangel C, Shu RG, Lazar LD, Vittinghoff E, Hsue PY, Marcus GM. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med. 2010;170(10):874-879.
83. Dattilo PB, Hailpern SM, Fearon K, Sohal D, Nordin C. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med. 2008;51(2):117-125.
84. Ramoska E, Sacchetti AD. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med. 1985;14(11):1112-1113. (Pubitemid 16201424)
85. Smith M, Garner D, Niemann JT. Pharmacologic interventions after an LD50 cocaine insult in a chronically instrumented rat model: are beta-blockers contraindicated? Ann Emerg Med. 1991;20(7):768-771.
86. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med. 1991;9(2):161-163.
87. Sofuoglu M, Brown S, Babb DA, et al. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend. 2000;60:69-76. (Pubitemid 30255987)
88. Hollander JE, Carter WA, Hoffman RS. Use of phentolamine for cocaine-induced myocardial ischemia [letter]. N Engl J Med. 1992;327(5):361.
89. Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine-association acute coronary syndrome (CAACS). J Med Toxicol. 2006;2(3):108-111.
90. Lange RA, Cigarroa RG, Yancy CW Jr, et al. Cocaine-induced coronaryartery vasoconstriction. N Engl J Med. 1989;321(23):1557-1562.
91. Menon DV, Wang Z, Fadel PJ, et al. Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am Coll Cardiol. 2007;50(7):626-633. (Pubitemid 47199006)
92. Hollander JE, Burstein JL, Hoffman RS, Shih RD, Wilson LD; Cocaine Associated Myocardial Infarction (CAMI) Study Group. Cocaine-associated myocardial infarction: clinical safety of thrombolytic therapy. Chest. 1995;107(5):1237-1241.
93. Hollander JE, Wilson LD, Leo PJ, Shih RD. Complications from the use of thrombolytic agents in patients with cocaine associated chest pain. J Emerg Med. 1996;14(6):731-736. (Pubitemid 27009224)
94. Singh S, Arora R, Khraisat A, et al. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature. J Cardiovasc Pharmacol Ther. 2007;12(4):298-303. (Pubitemid 350264694)
95. Karlsson G, Rehman J, Kalaria V, Breall JA. Increased incidence of stent thrombosis in patients with cocaine use. Catheter Cardiovasc Interv. 2007;69(7):955-958. (Pubitemid 46897927)
96. King SB III, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2008;117:261-295.